Total Payments
$5,324
2024 Payments
$984.60
Companies
25
Transactions
127
Medicare Patients
1,651
Medicare Billing
$183,109
Payment Breakdown by Category
Food & Beverage$4,689 (88.1%)
Travel$634.80 (11.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,689 | 125 | 88.1% |
| Travel and Lodging | $634.80 | 2 | 11.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,335 | 33 | $0 (2024) |
| Vertiflex, Inc. | $836.86 | 6 | $0 (2019) |
| Abbott Laboratories | $666.00 | 12 | $0 (2024) |
| Vertos Medical, Inc. | $563.50 | 10 | $0 (2023) |
| Relievant Medsystems, Inc. | $513.68 | 7 | $0 (2023) |
| SPR Therapeutics, Inc | $324.49 | 22 | $0 (2024) |
| Stryker Corporation | $174.13 | 1 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $141.55 | 9 | $0 (2024) |
| PAINTEQ LLC | $135.40 | 2 | $0 (2024) |
| Saluda Medical Americas, Inc. | $102.57 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.60 | 28 | Stryker Corporation ($174.13) |
| 2023 | $625.87 | 24 | SPR Therapeutics, Inc ($178.20) |
| 2022 | $1,113 | 17 | Boston Scientific Corporation ($569.15) |
| 2021 | $838.89 | 11 | BOSTON SCIENTIFIC CORPORATION ($341.78) |
| 2020 | $12.89 | 1 | Collegium Pharmaceutical, Inc. ($12.89) |
| 2019 | $1,236 | 25 | Vertiflex, Inc. ($836.86) |
| 2018 | $393.99 | 13 | Abbott Laboratories ($224.57) |
| 2017 | $118.41 | 8 | Arbor Pharmaceuticals, Inc. ($31.29) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $138.51 | General |
| Category: Neuromodulation | ||||||
| 11/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Opioid Analgesic | ||||||
| 11/10/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $36.85 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/09/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $65.72 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/09/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: Pain management | ||||||
| 11/08/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $174.13 | General |
| Category: INSTRUMENTS | ||||||
| 11/08/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: Pain Management | ||||||
| 11/07/2024 | Medtronic, Inc. | INCEPTIV (Device) | Food and Beverage | In-kind items and services | $76.24 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/03/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $76.23 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/21/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $3.36 | General |
| Category: Pain management | ||||||
| 10/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Opioid Analgesic | ||||||
| 10/10/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $36.72 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/26/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: Pain management | ||||||
| 09/24/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $1.18 | General |
| Category: Pain management | ||||||
| 09/16/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $0.41 | General |
| Category: Pain management | ||||||
| 08/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.30 | General |
| Category: Opioid Analgesic | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: PAIN | ||||||
| 05/15/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $45.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/06/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $8.27 | General |
| Category: Pain management | ||||||
| 05/03/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $4.01 | General |
| Category: Pain management | ||||||
| 05/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: Opioid Analgesic | ||||||
| 04/17/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $3.69 | General |
| Category: Pain management | ||||||
| 02/12/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $9.15 | General |
| Category: Pain management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 347 | 416 | $219,273 | $40,990 |
| 2022 | 14 | 432 | 510 | $263,693 | $49,067 |
| 2021 | 14 | 451 | 530 | $238,374 | $47,821 |
| 2020 | 14 | 421 | 533 | $242,590 | $45,231 |
Total Patients
1,651
Total Services
1,989
Medicare Billing
$183,109
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 20 | 20 | $52,000 | $8,825 | 17.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 24 | 29 | $35,872 | $6,184 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 61 | $10,980 | $5,201 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 70 | $8,400 | $4,459 | 53.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 43 | 51 | $24,225 | $3,845 | 15.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 17 | 28 | $24,246 | $2,840 | 11.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 24 | 30 | $14,890 | $1,975 | 13.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 20 | 21 | $11,040 | $1,894 | 17.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 17 | 28 | $12,455 | $1,613 | 12.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 14 | 21 | $14,458 | $1,581 | 10.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 13 | 15 | $7,245 | $1,245 | 17.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 17 | 18 | $2,862 | $1,096 | 38.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 24 | 24 | $600.00 | $232.32 | 38.7% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2022 | 23 | 23 | $59,800 | $10,179 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 95 | $17,100 | $8,347 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 73 | $8,760 | $4,876 | 55.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 19 | 23 | $33,178 | $4,529 | 13.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 44 | 54 | $25,650 | $3,774 | 14.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 22 | 35 | $27,445 | $3,318 | 12.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 34 | 40 | $24,000 | $3,295 | 13.7% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 18 | 19 | $3,040 | $2,038 | 67.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 22 | 35 | $14,100 | $1,895 | 13.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 29 | 30 | $4,770 | $1,836 | 38.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2022 | 19 | 24 | $11,592 | $1,514 | 13.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 19 | 21 | $15,858 | $1,472 | 9.3% |
About Dr. Robert Tiso, MD
Dr. Robert Tiso, MD is a Pain Medicine healthcare provider based in North Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942295092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Tiso, MD has received a total of $5,324 in payments from pharmaceutical and medical device companies, with $984.60 received in 2024. These payments were reported across 127 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,689).
As a Medicare-enrolled provider, Tiso has provided services to 1,651 Medicare beneficiaries, totaling 1,989 services with total Medicare billing of $183,109. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location North Syracuse, NY
- Active Since 09/14/2005
- Last Updated 02/04/2014
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1942295092
Products in Payments
- Superion ISS (Device) $836.86
- mild Device Kit (Device) $563.50
- Intracept (Device) $513.68
- Superion Indirect Decompression System (Device) $336.72
- SPRINT PNS System (Device) $324.49
- SPECTRA WAVEWRITER (Device) $191.98
- Superion (Device) $184.74
- WaveWriter Alpha Prime 16 (Device) $183.20
- MILD DEVICE KIT (Device) $174.13
- Proclaim IPG (Device) $158.52
- GENERAL PAIN MANAGEMENT (Device) $152.11
- Axium INS DRG IPG (Device) $142.07
- ETERNA (Device) $138.51
- PAINTEQ (Device) $135.40
- XTAMPZA (Drug) $126.25
- General - Pain Management (Device) $105.98
- Evoke (Device) $102.57
- Proclaim Family of SCS IPGs (Device) $80.49
- INCEPTIV (Device) $76.24
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $76.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.